Massachusetts College of Liberal Arts

Bryan Hanson Named CEO of 3M's Health Care Business Group

Retrieved on: 
Tuesday, August 22, 2023
Minimally invasive procedure, Walgreens Boots Alliance, Massachusetts College of Liberal Arts, Medical device, Senior, Pharmacia, Surgery, Information technology, Zimmer Biomet, Culture, Schering-Plough, Women's Health Care Nurse Practitioner-Board Certified, Roman, Pharmacia & Upjohn, Bristol Myers Squibb, Sale, Cox, Cardinal Health, Patient, Health care, Texas Instruments, Outline of health sciences, Seattle Mariners, Growth, Medtech, NYSE, Management, Pharmaceutical industry, Nursing, AmeriCares, Medtronic, Novartis, Covidien

Hanson will join 3M on Sept. 1 as CEO of the Health Care Business Group.

Key Points: 
  • Hanson will join 3M on Sept. 1 as CEO of the Health Care Business Group.
  • 3M's Health Care Business Group, with $8.4 billion in sales in 2022, is a diversified health care technology leader with a deep and diverse portfolio of trusted brands, global capabilities, and leadership in attractive end market segments such as wound care, oral care, health care IT, and biopharma filtration.
  • As a standalone business, Health Care will be well-positioned to deliver industry-leading innovation that enables better, smarter, and safer health care for patients worldwide.
  • "I am honored and excited to join 3M's Health Care Business Group at such an important time in its evolution," said Hanson.

Ambrx Appoints Renu Vaish, M.Sc., as Chief Regulatory Officer to Lead Regulatory Affairs

Retrieved on: 
Tuesday, August 1, 2023
Massachusetts College of Liberal Arts, Employment, Health policy, Senior, Concordia University, Prostate, American depositary receipt, Molecular biology, Celgene, SAN, Outline of health sciences, ADC, Merck, Kite Pharma, Regulatory affairs, Therapy, Management, Pharmaceutical industry, Science

SAN DIEGO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc. (“Ambrx” or the “Company”) (NASDAQ: AMAM), today announced the appointment of Renu Vaish, M.Sc., as Chief Regulatory Officer.

Key Points: 
  • SAN DIEGO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc. (“Ambrx” or the “Company”) (NASDAQ: AMAM), today announced the appointment of Renu Vaish, M.Sc., as Chief Regulatory Officer.
  • Ms. Vaish will be responsible for overseeing and designing the Company’s global regulatory strategy and will report to the Company’s President and Chief Executive Officer, Daniel J. O’Connor.
  • She has held senior regulatory leadership positions at Celgene, Merck and Kite Pharma, as well as other biopharma companies.
  • Her successful track record of achieving results in a variety of diverse, global regulatory and quality settings will be a significant asset to Ambrx.

COLLEGE POSSIBLE CATALYZE EXPANDS SERVICES IN CALIFORNIA TO SUPPORT STUDENT RETENTION

Retrieved on: 
Tuesday, May 2, 2023
Cal Poly San Luis Obispo College of Engineering, Massachusetts College of Liberal Arts, AmeriCorps, Learning, University, College, Catalysis, California State University, San Bernardino, Liberal arts education, University of California, Santa Cruz, University of California, Institutional research, College Possible, Pell, California Polytechnic State University, San Luis Obispo, Student, Cal Poly, ABC, Achievement Medal, Financial management, Family, CSUSB, Tutoring, Nursing, Partnership

ST. PAUL, Minn., May 2, 2023 /PRNewswire/ -- College Possible Catalyze announced this week that it has launched new partnerships with three California universities to expand its college success support by more than 1,400 students.

Key Points: 
  • ST. PAUL, Minn., May 2, 2023 /PRNewswire/ -- College Possible Catalyze announced this week that it has launched new partnerships with three California universities to expand its college success support by more than 1,400 students.
  • "College Possible is thrilled to expand its footprint with new institutional partners California State - San Bernardino, University of California - Santa Cruz, and Cal Poly - San Luis Obispo," said Catherine Marciano, College Possible Vice President of Partnerships.
  • California State University - San Bernardino (CSUSB) and College Possible are aligned in the mission to improve college access among underrepresented groups.
  • Their partnership with College Possible Catalyze will serve 280 students in the College of Liberal Arts each year with a focus on men of color.

Comera Life Sciences Appoints Janice Marie McCourt as Chief Business Officer

Retrieved on: 
Wednesday, November 9, 2022
Sumathi Best Television Current Reporting Award, GLOBE, CMRA, IV, Nasdaq, Forward-looking statement, Marketing, Death of Janice Marie Young, Business development, Massachusetts College of Liberal Arts, Partnership, Research, Risk, Financial compensation, Technology, Board, Specialization, Heat Biologics, COVID-19, Drug Development and Industrial Pharmacy, Therapy, SEC, Medicine, Safety, Freedom, Senior, Company, Employment, MBA, Biotechnology, University, Patient, University of Phoenix, Growth, Heart, CEO, Outline of health sciences, Industry, Corporate development, Hotel manager, Abbott Laboratories, Pharmaceutical industry, Management, Pharmacy, Takeda, UnitedHealth Group

WOBURN, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today announced the appointment of Janice Marie McCourt as Chief Business Officer.

Key Points: 
  • WOBURN, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today announced the appointment of Janice Marie McCourt as Chief Business Officer.
  • We are delighted to welcome Janice to our leadership team as our Chief Business Officer at this critical time of accelerated growth, said Jeffrey Hackman, Chief Executive Officer and Chairman of Comera.
  • Comeras expertise and commitment to bringing innovative solutions to patients coupled with its exciting growth prospects makes this an exciting time to join their team, said Janice Marie McCourt, Chief Business Officer of Comera.
  • To learn more about the Comera Life Sciences mission, as well as the proprietary SQore platform, visit https://comeralifesciences.com/ .

Clearwater Executive Chairman Bob Chaput Is Recognized as NACD Directorship Certified®

Retrieved on: 
Monday, October 17, 2022
ECRM, Risk management, Mathematics, NACD, Security operations center, Certification, Education, Organization, Massachusetts College of Liberal Arts, Privacy, HIPAA, Corporation, National Association, Chaput, National Association of Corporate Directors, CEO, Awareness, Liberal arts education, Clark University, Compliance, Management

NASHVILLE, Tenn., Oct. 17, 2022 /PRNewswire-PRWeb/ -- Clearwater today announced that the National Association of Corporate Directors (NACD) recently recognized Bob Chaput, company Founder and Executive Chairman, as NACD Directorship Certified®. Directors who earn this designation signal to boards, investors, and other stakeholders that they are keeping on top of the emerging issues and trends impacting financial performance, disrupting business models, and changing the competitive landscape.

Key Points: 
  • NASHVILLE, Tenn., Oct. 17, 2022 /PRNewswire-PRWeb/ -- Clearwater today announced that the National Association of Corporate Directors (NACD) recently recognized Bob Chaput, company Founder and Executive Chairman, as NACD Directorship Certified.
  • "I am honored to join the distinguished and diverse group of NACD Certified Directors who are committed to advancing the highest standards of boardroom excellence," said Bob Chaput, NACD.DC.
  • In addition to the NACD.DC Directorship Certification, Chaput holds numerous certifications in privacy, security, and cyber risk management.
  • "NACD Certified Directors demonstrate their keen awareness that directorship is a profession that, like all professions, requires continuous learning," said Peter R. Gleason, NACD's CEO.

ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs

Retrieved on: 
Monday, August 8, 2022
FDA, Woman, Paper, U.S. Securities and Exchange Commission, Degenerative disease, Principal, Lists of diseases, Urology, Liberal arts education, CNS, GLOBE, CEO, Lists of television programs, Royal, Growth, Brain, Leadership, Southern New Hampshire University, Bachelor, Police, Security (finance), Research, Radiology, Patient, Quality of life, Therapy, COVID-19, Company, Massachusetts College of Liberal Arts, Ides, Regulatory affairs, Medtech, Public health, Public, Particular, Nasdaq, Solution, Biochemistry, Biopsy, Management, Medical device, Risk management, Northeastern University

Mary is a perfect example of an experienced functional leader capable of defining a Regulatory Strategy and putting the people and processes in place to execute.

Key Points: 
  • Mary is a perfect example of an experienced functional leader capable of defining a Regulatory Strategy and putting the people and processes in place to execute.
  • The Regulatory Affairs function will be one of our biggest strengths as we support our growing portfolio of pharma and device partners and our global installed base.
  • Mary is also a frequent podium speaker and panelist on a range of topics including MedTech, regulatory affairs, and women in healthcare.
  • Before joining the Company, she was Senior Vice President of Regulatory Affairs at Alira Health.

Women's Power Gap Campaign's Annual Progress Report Reveals Stalled Progress in Overall Number of Women Presidents at Massachusetts Colleges and Universities

Retrieved on: 
Thursday, July 7, 2022
Mount Holyoke College, University of Massachusetts Amherst, Color, CEO, Bay State College, R1, Research, University, Technology, Massachusetts College of Liberal Arts, Doctor of Philosophy, School, Foot, Massachusetts Institute of Technology, Assumption College, Harvard University, Smith College, Gaps, Parity, Chancellor (education), Emerson College, Tufts University, Commonwealth, Eos, Leadership, News, Rivian, Roxbury Community College, Worcester Polytechnic Institute, Management, Medicine, Woman

BOSTON, July 7, 2022 /PRNewswire/ -- Newly released data by the Eos Foundation's Women's Power Gap Campaign reveals that since 2018 the number of women presidents in the state has plateaued at 34%, just 1% more than when the study began. In the same time period, the number of women of color presidents has doubled from 6% to 12% and the number of women board chairs increased from 27% to 37%. However, no women presidents have been Latinx or Indigenous. All advancement for women of color is represented by the appointments of one multiracial, three Asian and six Black women presidents.

Key Points: 
  • All advancement for women of color is represented by the appointments of one multiracial, three Asian and six Black women presidents.
  • The Women's Power Gap Campaign began tracking top leadership in higher education institutions throughout the Commonwealth in 2018.
  • This report, The Massachusetts College and University Presidents & Board Chairs 2022 Diversity Progress Snapshot , shows we have made some significant progress but still have far to go.
  • Of note:
    In 2019, community colleges reached gender parity with 53% having women presidents but now just 36% have women leaders.

The Standard Hires Mike Shamon as Stable Value Sales Director

Retrieved on: 
Tuesday, June 21, 2022
Professional Services, Insurance, Human Resources, Finance, Industry, Business administration, Liberal arts education, StanCorp Financial Group, The Standard, Massachusetts College of Liberal Arts, The arts, MotorMouf aka Khia Shamone, JPMorgan Chase, LinkedIn, Growth, Consultant, Standard Insurance Company, Putnam Investments, Bachelor of Arts in Child Advocacy, Twitter, Nichols College, Standard, Multimedia, FINRA, Management, Financial adviser, Facebook

The Standard announced the hiring of Mike Shamon as stable value sales director.

Key Points: 
  • The Standard announced the hiring of Mike Shamon as stable value sales director.
  • He is responsible for growth through new investment-only stable value sales in the Eastern region and is based in the greater Boston, Massachusetts, area.
  • Mike has a deep understanding of the stable value marketplace and long-term experience managing institutional relationships.
  • Mikes consulting expertise and commitment to service will significantly benefit our advisor partners and mutual clients, added Joe Bruns, stable value sales senior director.

Sunstone Innovation Challenge Awards $25,000 to Winning Startups at CSULB

Retrieved on: 
Wednesday, April 20, 2022
Small Business, Banking, Professional Services, Finance, Patent, CSU, Athlete, CEO, Government, California State University, CSULB, Marketing, College, International, AEP, Work, Creativity, The arts, Education, Mentorship, Financial technology, Female, UC, Maintenance, Innovation, Entrepreneurship, Massachusetts College of Liberal Arts, California State University, Long Beach, Management, Engineering, Sunstone, Business

The winners of the Sunstone Innovation Challenge were announced following final pitch presentations on Thursday, April 14th.

Key Points: 
  • The winners of the Sunstone Innovation Challenge were announced following final pitch presentations on Thursday, April 14th.
  • International investment firm Sunstone Management partnered with California State University Long Beach (CSULB) Institute for Innovation & Entrepreneurship to sponsor the universitys 12th annual campus-wide business plan competition.
  • The Sunstone Innovation Challenge broadens the runway and lengthens the experience for these student entrepreneurs.
  • Entrepreneurship is about creating something viable and enduring, and I applaud Sunstone for their invaluable support, said Michael Solt, Dean of the College of Business.

Rheos Medicines Appoints Katerina Leftheris, Ph.D., as SVP of Drug Discovery and Nabil Uddin, Pharm.D., as VP of Strategy and Business Development

Retrieved on: 
Thursday, April 14, 2022
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, Vitae, National Council, Drug development, Drug discovery, PSC, University of California, San Diego, Fibrosis, Idiopathic pulmonary fibrosis, Chapel Hill, Primary sclerosing cholangitis, Corporation, McMaster University, Autism, Cystic fibrosis, NASH, American Chemical Society, Pharming, Smith College, Vertex Pharmaceuticals, Science, Third Rock Ventures, Inflammation, Novartis, Doctor of Philosophy, Autoimmunity, Lists of diseases, Strategic planning, Program, Goal, Patient, Massachusetts College of Liberal Arts, LinkedIn, Growth, Fragile X syndrome, Publication, University of North Carolina at Charlotte, University, IPF, Business development, Precision medicine, Therapy, D, Pharmaceutical industry, Management, Biology, Chemistry

Katerina brings extensive experience in small molecule drug discovery and a successful track record for advancing drug candidates to the clinic in a range of therapeutic areas.

Key Points: 
  • Katerina brings extensive experience in small molecule drug discovery and a successful track record for advancing drug candidates to the clinic in a range of therapeutic areas.
  • I look forward to applying my experience to help advance Rheoss pipeline to develop precision medicines for autoimmune and inflammatory diseases, said Dr. Leftheris.
  • It is exciting to be part of a new drug development paradigm at Rheos to address the heterogeneity of immune-mediated diseases and take on the vast unmet needs of patients.
  • Throughout her career, she has led teams that advanced more than 15 small molecule drug compounds into clinical development spanning many molecular targets.